Enzyme Replacement Therapy Market is Expanding Steadily

Aug 03, 2018
By Pharmaceutical Executive Editors

Future Market Insights recently published research findings that the global enzyme replacement therapy market is predicted to increase at 6.5% CAGR over the forecast period 2018–2028. It also finds the global market for enzyme replacement therapy is expected to exceed $ 13,776.2 million (US dollars) by the end of 2028, attesting the highest growth rate by Japan, which is expected to expand at 12.5% CAGR over 2018–2028. The developing healthcare infrastructure and awareness programs in regions of Asia Pacific and China is expected to play a part in revenue growth for the global enzyme replacement therapy market.

Some key research findings include:

  • Enzyme replacement therapy is used in the treatment of rare diseases and the global market is projected to create incremental opportunity of $ 6,448.3 million (US dollars) between 2018 and 2028
  • When compared to other established markets such as North America, the enzyme replacement therapy markets in Japan and Western Europe are expected to witness fast and steady growth, partly due to the increasing governmental support and growing demand for enzyme replacement therapy for the treatment of rare diseases.

 

 

native1_300x100
lorem ipsum